Stanford University
Showing 31,541-31,560 of 37,039 Results
-
Molly Tanenbaum
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Associate Professor (By courtesy), Pediatrics - EndocrinologyBioDr. Tanenbaum is a clinical psychologist and clinical researcher committed to improving health and quality of life outcomes for people with diabetes. Dr. Tanenbaum’s research focuses on two main areas: 1) understanding and optimizing the role of technology (e.g. mobile technology/mHealth, diabetes devices, automated insulin delivery), and the feedback technology provides, to improve diabetes management; and 2) understanding the emotional experience of living with diabetes. Her recent work focused on developing a telehealth-based behavioral intervention for adults with type 1 diabetes to support adoption and sustained use of continuous glucose monitoring technology. She has expertise in using qualitative and mixed methods to take a human centered approach to understanding the context of living with and managing a chronic condition. Dr. Tanenbaum also has an interest in compassion-based approaches to addressing diabetes distress. As a licensed clinical psychologist, Dr. Tanenbaum provides consultation and behavioral medicine interventions with people living with diabetes.
-
Ariel Yingqi Tang
Postdoctoral Scholar, Political Science
Current Research and Scholarly InterestsEnlightenment political thought, contemporary political theory, history of universities, history of knowledge, philosophical anthropology, philosophy and literature.
-
Hua Tang
Professor of Genetics and, by courtesy, of Statistics
Current Research and Scholarly InterestsDevelop statistical and computational methods for population genomics analyses; modeling human evolutionary history; genetic association studies in admixed populations.
-
Jean Y. Tang MD PhD
Professor of Dermatology
On Partial Leave from 05/01/2026 To 04/30/2027Current Research and Scholarly InterestsMy research focuses on 2 main areas:
1. Skin cancer:
- New therapeutics to treat and prevent non-melanoma skin cancer, especially by targeting the Hedgehog signaling pathway for BCC tumors
- Genomic analysis of drug-resistant cancers
- Identifying risk factors for skin cancer in the Women's Health Initiative
2. Epidermolysis Bullosa: gene therapy and protein therapy to replace defective/absent Collagen 7 in children and adults with Recessive Dystrophic EB
